| dc.contributor.author | Villafuerte-Gutierrez, Paola | |
| dc.contributor.author | Villalon, Lucia | |
| dc.contributor.author | Losa, Juan E | |
| dc.contributor.author | Henriquez-Camacho, Cesar | |
| dc.date.accessioned | 2024-01-31T07:43:04Z | |
| dc.date.available | 2024-01-31T07:43:04Z | |
| dc.date.issued | 2014-11 | |
| dc.identifier.citation | Villafuerte-Gutierrez P, Villalon L, Losa JE, Henriquez-Camacho C. Treatment of febrile neutropenia and prophylaxis in hematologic malignancies: a critical review and update. Adv Hematol. 2014;2014:986938. doi: 10.1155/2014/986938. Epub 2014 Nov 27. Erratum in: Adv Hematol. 2019 Jul 16;2019:4120631. PMID: 25525436; PMCID: PMC4265549. | es |
| dc.identifier.uri | https://hdl.handle.net/10115/29308 | |
| dc.description.abstract | Febrile neutropenia is one of the most serious complications in patients with haematological malignancies and chemotherapy. A prompt identification of infection and empirical antibiotic therapy can prolong survival. This paper reviews the guidelines about febrile neutropenia in the setting of hematologic malignancies, providing an overview of the definition of fever and neutropenia, and categories of risk assessment, management of infections, and prophylaxis. | es |
| dc.language.iso | eng | es |
| dc.rights | Attribution 4.0 International | |
| dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | |
| dc.subject | febrile neutropenia | es |
| dc.subject | prophylaxis | es |
| dc.subject | hematologic malignancies | es |
| dc.title | Treatment of febrile neutropenia and prophylaxis in hematologic malignancies: a critical review and update | es |
| dc.type | info:eu-repo/semantics/article | es |
| dc.identifier.doi | 10.1155/2014/986938 | es |
| dc.rights.accessRights | info:eu-repo/semantics/openAccess | es |
Except where otherwise noted, this item's license is described as Attribution 4.0 International